{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:47:54Z","timestamp":1791089274486,"version":"4.1.0"},"reference-count":123,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1097\/med.0000000000000044","type":"journal-article","created":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T18:41:43Z","timestamp":1392230503000},"page":"109-120","source":"Crossref","is-referenced-by-count":42,"title":["Type 2 diabetes and cardiovascular disease"],"prefix":"10.1097","volume":"21","author":[{"given":"Joshua J.","family":"Joseph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherita Hill","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20211004","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.2337\/dc12-1513","article-title":"All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database.","volume":"36","author":"Taylor","year":"2013","journal-title":"Diabetes Care"},{"key":"R2-7-20211004","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"R3-7-20211004","first-page":"S11","article-title":"Standards of medical care in diabetes -- 2013.","volume":"36","year":"2012","journal-title":"Diabetes Care"},{"key":"R4-7-20211004","first-page":"1575","article-title":"2 diabetes mellitus.","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"key":"R5-7-20211004","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"R6-7-20211004","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.2010.884","article-title":"Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.","volume":"304","author":"Cooper-DeHoff","year":"2010","journal-title":"J Am Med Assoc"},{"key":"R7-7-20211004","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/archinternmed.2012.3147","article-title":"Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus: systematic review and meta-analysis.","volume":"172","author":"McBrien","year":"2012","journal-title":"Arch Intern Med"},{"key":"R8-7-20211004","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/HJH.0b013e32836123aa","article-title":"Blood pressure levels and risk of cardiovascular events and mortality in type-2 diabetes: cohort study of 34009 primary care patients.","volume":"31","author":"Sundstrom","year":"2013","journal-title":"J Hypertens"},{"key":"R9-7-20211004","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2337\/dc12-0284","article-title":"Benefits of early hypertension control on cardiovascular outcomes in patients with diabetes.","volume":"36","author":"OConnor","year":"2012","journal-title":"Diabetes Care"},{"key":"R10-7-20211004","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(09)60697-8","article-title":"Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.","volume":"373","author":"Ray","year":"2009","journal-title":"Lancet"},{"key":"R11-7-20211004","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7326\/0003-4819-151-6-200909150-00137","article-title":"Systematic review: glucose control and cardiovascular disease in type 2 diabetes.","volume":"151","author":"Kelly","year":"2009","journal-title":"Ann Intern Med"},{"key":"R12-7-20211004","doi-asserted-by":"crossref","first-page":"d4169","DOI":"10.1136\/bmj.d4169","article-title":"Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.","volume":"343","author":"Boussageon","year":"2011","journal-title":"BMJ"},{"key":"R13-7-20211004","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2337\/dc12-0719","article-title":"Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease.","volume":"36","author":"Hong","year":"2012","journal-title":"Diabetes Care"},{"key":"R14-7-20211004","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34).","volume":"352","author":"Turner","year":"1998","journal-title":"Lancet"},{"key":"R15-7-20211004","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1001\/archinte.168.19.2070","article-title":"Cardiovascular outcomes in trials of oral diabetes medications: a systematic review.","volume":"168","author":"Selvin","year":"2008","journal-title":"Arch Intern Med"},{"key":"R16-7-20211004","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2337\/dc07-1868","article-title":"DREAM Trial InvestigatorsEffects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.","volume":"31","author":"Dagenais","year":"2008","journal-title":"Diabetes Care"},{"key":"R17-7-20211004","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.","volume":"369","author":"Scirica","year":"2013","journal-title":"N Engl J Med"},{"key":"R18-7-20211004","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","article-title":"Alogliptin after acute coronary syndrome in patients with type 2 diabetes.","volume":"369","author":"White","year":"2013","journal-title":"N Engl J Med"},{"key":"R19-7-20211004","first-page":"319","article-title":"N Engl J M","volume":"367","year":"2012","journal-title":"ed"},{"key":"R20-7-20211004","first-page":"145","article-title":"2 diabetes.","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"key":"R21-7-20211004","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet.","volume":"368","author":"Estruch","year":"2013","journal-title":"N Engl J Med"},{"key":"R22-7-20211004","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1001\/jamainternmed.2013.6473","article-title":"Vegetarian dietary patterns and mortality in Adventist health study 2.","volume":"173","author":"Orlich","year":"2013","journal-title":"JAMA Intern Med"},{"key":"R23-7-20211004","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.2337\/dc12-0193","article-title":"Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes.","volume":"35","author":"Romeo","year":"2012","journal-title":"Diabetes Care"},{"key":"R24-7-20211004","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa1200225","article-title":"Bariatric surgery versus intensive medical therapy in obese patients with diabetes.","volume":"366","author":"Schauer","year":"2012","journal-title":"N Engl J Med"},{"key":"R25-7-20211004","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.2337\/dc12-1596","article-title":"Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment.","volume":"36","author":"Kashyap","year":"2013","journal-title":"Diabetes Care"},{"key":"R26-7-20211004","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa1200111","article-title":"Bariatric surgery versus conventional medical therapy for type 2 diabetes.","volume":"366","author":"Mingrone","year":"2012","journal-title":"N Engl J Med"},{"key":"R27-7-20211004","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2337\/dc11-2289","article-title":"Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity.","volume":"35","author":"Cohen","year":"2012","journal-title":"Diabetes Care"},{"key":"R28-7-20211004","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1001\/jama.2013.5835","article-title":"Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension and hyperlipidemia.","volume":"309","author":"Ikramuddin","year":"2013","journal-title":"J Am Med Assoc"},{"key":"R29-7-20211004","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.jacc.2006.12.048","article-title":"The effect of pioglitazone on recurrent myocardial infarction in 2445 patients with type 2 diabetes and previous myocardial infarction.","volume":"49","author":"Erdmann","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R30-7-20211004","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2337\/dc05-2415","article-title":"Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN).","volume":"29","author":"Knopp","year":"2006","journal-title":"Diabetes Care"},{"key":"R31-7-20211004","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"R32-7-20211004","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18686 people with diabetes in 14 randomised trials of statins: a meta-analysis.","volume":"371","author":"Trialists","year":"2008","journal-title":"Lancet"},{"key":"R33-7-20211004","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"R34-7-20211004","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.","volume":"380","author":"Ridker","year":"2012","journal-title":"Lancet"},{"key":"R35-7-20211004","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.amjcard.2012.12.037","article-title":"Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus.","volume":"111","author":"Navarese","year":"2013","journal-title":"Am J Cardiol"},{"key":"R36-7-20211004","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1517\/14656566.2013.810210","article-title":"Statin therapy on glycaemic control in type 2 diabetes: a meta-analysis.","volume":"14","author":"Zhou","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"R37-7-20211004","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa010492","article-title":"Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.","volume":"345","author":"Hu","year":"2001","journal-title":"N Engl J Med"},{"key":"R38-7-20211004","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2337\/dc06-2544","article-title":"Effect of BMI on lifetime risk for diabetes in the U.S.","volume":"30","author":"Narayan","year":"2007","journal-title":"Diabetes Care"},{"key":"R39-7-20211004","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/2012.jama.11132","article-title":"Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults.","volume":"308","author":"Neeland","year":"2012","journal-title":"J Am Med Assoc"},{"key":"R40-7-20211004","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0002-9149(77)80104-5","article-title":"Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study.","volume":"39","author":"Rabkin","year":"1977","journal-title":"Am J Cardiol"},{"key":"R41-7-20211004","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.CIR.67.5.968","article-title":"Obesity as an independent risk factor for cardiovascular disease: a 26- year follow-up of participants in the Framingham Heart Study.","volume":"67","author":"Hubert","year":"1983","journal-title":"Circulation"},{"key":"R42-7-20211004","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/archinte.162.16.1867","article-title":"Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.","volume":"162","author":"Wilson","year":"2002","journal-title":"Arch Intern Med"},{"key":"R43-7-20211004","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome.","volume":"444","author":"Despres","year":"2006","journal-title":"Nature"},{"key":"R44-7-20211004","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes.","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"key":"R45-7-20211004","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nature05483","article-title":"Adipocytes as regulators of energy balance and glucose homeostasis.","volume":"444","author":"Rosen","year":"2006","journal-title":"Nature"},{"key":"R46-7-20211004","doi-asserted-by":"crossref","first-page":"H2031","DOI":"10.1152\/ajpheart.01058.2004","article-title":"Adipokines: molecular links between obesity and atheroslcerosis.","volume":"288","author":"Lau","year":"2005","journal-title":"AJP Heart Circ Physiol"},{"key":"R47-7-20211004","doi-asserted-by":"crossref","first-page":"III","DOI":"10.1161\/01.CIR.0000131517.20177.5a","article-title":"Beneficial cardiovascular pleiotropic effects of statins.","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"R48-7-20211004","first-page":"145","article-title":"2 diabetes.","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"key":"R49-7-20211004","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of bariatric surgery on mortality in Swedish obese subjects.","volume":"357","author":"Sjostrom","year":"2007","journal-title":"N Engl J Med"},{"key":"R50-7-20211004","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1056\/NEJMoa1112082","article-title":"Bariatric surgery and prevention of type 2 diabetes in swedish obese subjects.","volume":"367","author":"Carlsson","year":"2012","journal-title":"N Engl J Med"},{"key":"R51-7-20211004","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2011.1914","article-title":"Bariatric surgery and long-term cardiovascular events.","volume":"307","author":"Sjostrom","year":"2012","journal-title":"J Am Med Assoc"},{"key":"R52-7-20211004","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1001\/jama.2013.4851","article-title":"Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes.","volume":"309","author":"Maggard-Gibbons","year":"2013","journal-title":"J Am Med Assoc"},{"key":"R53-7-20211004","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1210\/er.2011-1044","article-title":"All bariatric surgeries are not created equal: insights from mechanistic comparisons.","volume":"33","author":"Stefater","year":"2012","journal-title":"Endocr Rev"},{"key":"R54-7-20211004","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"key":"R55-7-20211004","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ijcard.2011.12.100","article-title":"Excess risk of mortality and cardiovascular events associated with smoking among patients with diabetes: meta-analysis of observational prospective studies.","volume":"167","author":"Qin","year":"2013","journal-title":"Int J Cardiol"},{"key":"R56-7-20211004","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archinte.162.3.273","article-title":"Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus.","volume":"162","author":"Al-Delaimy","year":"2002","journal-title":"Arch Intern Med"},{"key":"R57-7-20211004","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/jama.2013.1644","article-title":"Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes.","volume":"309","author":"Clair","year":"2013","journal-title":"J Am Med Assoc"},{"key":"R58-7-20211004","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1001\/jama.2008.623","article-title":"Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes.","volume":"300","author":"Ogawa","year":"2008","journal-title":"J Am Med Assoc"},{"key":"R59-7-20211004","doi-asserted-by":"crossref","first-page":"a1840","DOI":"10.1136\/bmj.a1840","article-title":"The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.","volume":"337","author":"Belch","year":"2008","journal-title":"BMJ"},{"key":"R60-7-20211004","first-page":"2694","article-title":"ADAAHAACCF scientific statement.","volume":"121","author":"Colwell","year":"2010","journal-title":"Circulation"},{"key":"R61-7-20211004","doi-asserted-by":"crossref","first-page":"b4531","DOI":"10.1136\/bmj.b4531","article-title":"Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.","volume":"339","author":"De Berardis","year":"2009","journal-title":"BMJ"},{"key":"R62-7-20211004","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1745-6215-8-21","article-title":"Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins.","volume":"8","author":"De Berardis","year":"2007","journal-title":"Trials"},{"key":"R64-7-20211004","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1378\/chest.11-1945","article-title":"Prevalence of diagnosed sleep apnea among patients with type 2 diabetes in primary care.","volume":"141","author":"Heffner","year":"2012","journal-title":"Chest J"},{"key":"R65-7-20211004","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1001\/archinternmed.2009.266","article-title":"A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study.","volume":"169","author":"Foster","year":"2009","journal-title":"Arch Intern Med"},{"key":"R66-7-20211004","first-page":"2169","article-title":"Association between treated and untreated obstructive sleep apnea and risk of hypertension.","volume":"307","author":"Agusti","year":"2012","journal-title":"J Am Med Assoc"},{"key":"R67-7-20211004","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacc.2013.05.045","article-title":"Obstructive sleep apnea.","volume":"62","author":"Drager","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R69-7-20211004","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1177\/1741826711426092","article-title":"Sleep loss due to worry and future risk of cardiovascular disease and all-cause mortality: the Scottish Health Survey.","volume":"19","author":"Hamer","year":"2011","journal-title":"Eur J Prev Cardiol"},{"key":"R70-7-20211004","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/JCN.0b013e31821e7ad1","article-title":"Sleep duration, snoring habits, and cardiovascular disease risk factors in an ethnically diverse population.","volume":"27","author":"Mosca","year":"2012","journal-title":"J Cardiovasc Nurs"},{"key":"R71-7-20211004","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.sleep.2004.06.003","article-title":"Associations of frequent sleep insufficiency with health-related quality of life and health behaviors.","volume":"6","author":"Strine","year":"2005","journal-title":"Sleep Med"},{"key":"R72-7-20211004","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2114\/jpa2.28.83","article-title":"Effects of meal habits and alcoholcigarette consumption on morningness-eveningness preference and sleep habits by Japanese female students aged 18-29.","volume":"28","author":"Nakade","year":"2009","journal-title":"J Physiol Anthropol"},{"key":"R74-7-20211004","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2869.2012.01043.x","article-title":"Bidirectional associations between insomnia symptoms and unhealthy behaviours: Insomnia symptoms and unhealthy behaviours.","volume":"22","author":"Haario","year":"2013","journal-title":"J Sleep Res"},{"key":"R76-7-20211004","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12170-013-0330-0","article-title":"Sleep and its relationship to racial and ethnic disparities in cardiovascular disease.","volume":"7","author":"Kingsbury","year":"2013","journal-title":"Curr Cardiovasc Risk Reports"},{"key":"R77-7-20211004","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.annepidem.2007.07.096","article-title":"Short sleep duration across income, education, and raceethnic groups: population prevalence and growing disparities during 34 years of follow-up.","volume":"17","author":"Stamatakis","year":"2007","journal-title":"Ann Epidemiol"},{"key":"R78-7-20211004","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/sleep\/31.5.645","article-title":"Associations of usual sleep duration with serum lipid and lipoprotein levels.","volume":"31","author":"Kaneita","year":"2008","journal-title":"Sleep"},{"key":"R79-7-20211004","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.2337\/db09-0699","article-title":"Sleep restriction for 1 week reduces insulin sensitivity in healthy men.","volume":"59","author":"Buxton","year":"2010","journal-title":"Diabetes"},{"key":"R80-7-20211004","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7326\/0003-4819-157-8-201210160-00005","article-title":"Impaired insulin signaling in human adipocytes after experimental sleep restriction: a randomized, crossover study.","volume":"157","author":"Broussard","year":"2012","journal-title":"Ann Intern Med"},{"key":"R81-7-20211004","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2337\/dc09-1124","article-title":"Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis.","volume":"33","author":"Cappuccio","year":"2009","journal-title":"Diabetes Care"},{"key":"R82-7-20211004","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1001\/archinte.166.16.1768","article-title":"Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus.","volume":"166","author":"Knutson","year":"2006","journal-title":"Arch Intern Med"},{"key":"R83-7-20211004","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-141-11-200412070-00008","article-title":"Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite.","volume":"141","author":"Spiegel","year":"2004","journal-title":"Ann Intern Med"},{"key":"R84-7-20211004","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2337\/diacare.29.03.06.dc05-0879","article-title":"Sleep duration as a risk factor for the development of type 2 diabetes.","volume":"29","author":"Yaggi","year":"2006","journal-title":"Diabetes Care"},{"key":"R85-7-20211004","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.sleep.2012.08.005","article-title":"Sleep duration versus sleep insufficiency as predictors of cardiometabolic health outcomes.","volume":"13","author":"Altman","year":"2012","journal-title":"Sleep Med"},{"key":"R86-7-20211004","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.HYP.27.6.1318","article-title":"Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder.","volume":"27","author":"Tochikubo","year":"1996","journal-title":"Hypertension"},{"key":"R87-7-20211004","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0895-7061(98)00200-3","article-title":"Effects of insufficient sleep on blood pressure in hypertensive patients: a 24-h study.","volume":"12","author":"Lusardi","year":"1999","journal-title":"Am J Hypertens"},{"key":"R88-7-20211004","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/ajh\/hpt044","article-title":"Sleep Duration and risk for hypertension in women: results from The Nurses Health Study.","volume":"26","author":"Gangwisch","year":"2013","journal-title":"Am J Hypertens"},{"key":"R89-7-20211004","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1001\/jama.2008.867","article-title":"Short sleep duration and incident coronary artery calcification.","volume":"300","author":"King","year":"2008","journal-title":"J Am Med Assoc"},{"key":"R90-7-20211004","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.diabres.2012.09.014","article-title":"Short sleep duration and type 2 diabetes enhance the risk of cardiovascular events in hypertensive patients.","volume":"98","author":"Eguchi","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"R91-7-20211004","doi-asserted-by":"crossref","first-page":"e14189","DOI":"10.1371\/journal.pone.0014189","article-title":"Insufficient rest or sleep and its relation to cardiovascular disease, diabetes and obesity in a national, multiethnic sample.","volume":"5","author":"Shankar","year":"2010","journal-title":"PLoS One"},{"key":"R92-7-20211004","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.5665\/sleep.1382","article-title":"Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence: The MORGEN Study.","volume":"34","author":"Hoevenaar-Blom","year":"2011","journal-title":"Sleep"},{"key":"R93-7-20211004","first-page":"1","article-title":"Sufficient sleep duration contributes to lower cardiovascular disease risk in addition to four traditional lifestyle factors: the MORGEN study.","volume":"0","author":"Hoevenaar-Blom","year":"2013","journal-title":"Eur J Prev Cardiol"},{"key":"R94-7-20211004","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1600-079X.2011.00892.x","article-title":"Synergism between melatonin and atorvastatin against endothelial cell damage induced by lipopolysaccharide: melatonin improves atorvastatin effects.","volume":"51","author":"Dayoub","year":"2011","journal-title":"J Pineal Res"},{"key":"R95-7-20211004","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/jpi.12070","article-title":"JAK2STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemiareperfusion injury.","volume":"55","author":"Yang","year":"2013","journal-title":"J Pineal Res"},{"key":"R96-7-20211004","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1600-079X.2007.00518.x","article-title":"Cardiovascular diseases: protective effects of melatonin.","volume":"44","author":"Tengattini","year":"2008","journal-title":"J Pineal Res"},{"key":"R97-7-20211004","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/01.HYP.0000113293.15186.3b","article-title":"Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension.","volume":"43","author":"Scheer","year":"2004","journal-title":"Hypertension"},{"key":"R98-7-20211004","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/ng.1053","article-title":"Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes.","volume":"44","author":"Bonnefond","year":"2012","journal-title":"Nat Genet"},{"key":"R99-7-20211004","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1001\/jama.2013.2710","article-title":"Melatonin secretion and the incidence of type 2 diabetes.","volume":"309","author":"McMullan","year":"2013","journal-title":"J Am Med Assoc"},{"key":"R100-7-20211004","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2337\/dc11-1405","article-title":"Racialethnic- and education-related disparities in the control of risk factors for cardiovascular disease among individuals with diabetes.","volume":"35","author":"Chatterji","year":"2011","journal-title":"Diabetes Care"},{"key":"R101-7-20211004","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.2337\/dc11-2495","article-title":"Mortality among low-income African Americans and whites with diabetes.","volume":"35","author":"Conway","year":"2012","journal-title":"Diabetes Care"},{"key":"R102-7-20211004","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2337\/dc11-2281","article-title":"Predictors of mortality over 8 years in type 2 diabetic patients: translating research into action for diabetes (TRIAD).","volume":"35","author":"McEwen","year":"2012","journal-title":"Diabetes Care"},{"key":"R103-7-20211004","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jdiacomp.2011.12.002","article-title":"Social adaptability index predicts overall mortality in patients with diabetes.","volume":"26","author":"Goldfarb-Rumyantzev","year":"2012","journal-title":"J Diabetes Complications"},{"key":"R104-7-20211004","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.socscimed.2012.06.003","article-title":"The contribution of stress to the social patterning of clinical and subclinical CVD risk factors in African Americans: The Jackson Heart Study.","volume":"75","author":"Gebreab","year":"2012","journal-title":"Soc Sci Med"},{"key":"R105-7-20211004","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/ajh.2011.98","article-title":"Socioeconomic position is positively associated with blood pressure dipping among African-American adults: the Jackson Heart Study.","volume":"24","author":"Hickson","year":"2011","journal-title":"Am J Hypertens"},{"key":"R106-7-20211004","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"R107-7-20211004","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(04)17019-0","article-title":"Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study.","volume":"364","author":"Rosengren","year":"2004","journal-title":"Lancet"},{"key":"R108-7-20211004","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.genhosppsych.2013.01.006","article-title":"Depression and risk of mortality in individuals with diabetes: a meta-analysis and systematic review.","volume":"35","author":"Park","year":"2013","journal-title":"Gen Hosp Psychiatry"},{"key":"R109-7-20211004","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/nur.20084","article-title":"Allostatic load and health disparities: a theoretical orientation.","volume":"28","author":"Carlson","year":"2005","journal-title":"Res Nurs Health"},{"key":"R110-7-20211004","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0018-506X(02)00024-7","article-title":"The concept of allostasis in biology and biomedicine.","volume":"43","author":"McEwen","year":"2003","journal-title":"Horm Behav"},{"key":"R111-7-20211004","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0197-4580(02)00027-1","article-title":"Sex, stress and the hippocampus: allostasis, allostatic load and the aging process.","volume":"23","author":"McEwen","year":"2002","journal-title":"Neurobiol Aging"},{"key":"R112-7-20211004","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nrendo.2009.106","article-title":"Stress and disorders of the stress system.","volume":"5","author":"Chrousos","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"R113-7-20211004","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJM199801153380307","article-title":"Protective and damaging effects of stress mediators.","volume":"338","author":"Flier","year":"1998","journal-title":"N Engl J Med"},{"key":"R114-7-20211004","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00006842-200205000-00004","article-title":"Social relationships, gender, and allostatic load across two age cohorts.","volume":"64","author":"Seeman","year":"2002","journal-title":"Psychosom Med"},{"key":"R115-7-20211004","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.healthplace.2011.03.009","article-title":"Allostatic load in an environmental riskscape: the role of stressors and gender.","volume":"17","author":"Mair","year":"2011","journal-title":"Health Place"},{"key":"R116-7-20211004","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1210\/jc.2009-0370","article-title":"The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis.","volume":"94","author":"Anagnostis","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R117-7-20211004","doi-asserted-by":"crossref","first-page":"E56","DOI":"10.1002\/oby.20047","article-title":"Diurnal salivary cortisol is associated with body mass index and waist circumference: The multiethnic study of atherosclerosis.","volume":"21","author":"Champaneri","year":"2013","journal-title":"Obesity"},{"key":"R118-7-20211004","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.metabol.2011.11.006","article-title":"Diurnal salivary cortisol and urinary catecholamines are associated with diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis.","volume":"61","author":"Champaneri","year":"2012","journal-title":"Metabolism"},{"key":"R119-7-20211004","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2174\/157339907782330021","article-title":"A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus.","volume":"3","author":"Golden","year":"2007","journal-title":"Curr Diabetes Rev"},{"key":"R120-7-20211004","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s11892-010-0148-9","article-title":"Biological basis of depression in adults with diabetes.","volume":"10","author":"Champaneri","year":"2010","journal-title":"Curr Diab Rep"},{"key":"R121-7-20211004","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/oby.2011.68","article-title":"Role of the gut in visceral fat inflammation and metabolic disorders.","volume":"19","author":"Lam","year":"2011","journal-title":"Obesity"},{"key":"R122-7-20211004","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.2174\/138161211798764843","article-title":"Pathophysiology of atherosclerosis: the role of inflammation.","volume":"17","author":"Tousoulis","year":"2011","journal-title":"Curr Pharm Des"},{"key":"R123-7-20211004","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.2174\/138161211798764825","article-title":"Potential pathogenic inflammatory mechanisms of endothelial dysfunction induced by type 2 diabetes mellitus.","volume":"17","author":"Kampoli","year":"2011","journal-title":"Curr Pharm Des"},{"key":"R124-7-20211004","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1753-0407.2011.00148.x","article-title":"Trends in the control of risk factors for cardiovascular disease among adults with diagnosed diabetes: findings from the National Health and Nutrition Examination Survey 1999-2008: cardiovascular risk factor control.","volume":"3","author":"Ford","year":"2011","journal-title":"J Diabetes"},{"key":"R125-7-20211004","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/1479164113496828","article-title":"Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease status.","volume":"10","author":"Wong","year":"2013","journal-title":"Diab Vasc Dis Res"},{"key":"R126-7-20211004","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jama.291.3.335","article-title":"Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes.","volume":"291","author":"Saydah","year":"2004","journal-title":"J Am Med Assoc"},{"key":"R127-7-20211004","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.jacc.2013.01.044","article-title":"Risk factor control for coronary artery disease secondary prevention in large randomized trials.","volume":"61","author":"Farkouh","year":"2013","journal-title":"J Am Coll Cardiol"}],"container-title":["Current Opinion in Endocrinology, Diabetes & Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201404000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T06:09:21Z","timestamp":1716530961000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201404000-00007"}},"subtitle":["what next?"],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":123,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0000000000000044","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}